Spinocerebellar Ataxia Type 12

Genetic Instabilities and Neurological Diseases

Volumn , Issue , 2006, Pages 461-473

  Holmes, Susan E ^a   O'Hearn, Elizabeth ^a   Cortez Apreza, Natividad ^a   Hwang, H S ^a   Ross, Christopher A ^a   Strack, S ^b   Margolis, Russell L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882523055     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369462-1/50032-6     Document Type: Chapter

References (63)

1. La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991, 352:77-79.
2. Margolis R.L. The spinocerebellar ataxias: Order emerges from chaos. Curr. Neurol. Neurosci. Rep. 2002, 2:447-456.
3. Schols L., Bauer P., Schmidt T., Schulte T., Riess O. Autosomal dominant cerebellar ataxias: Clinical features, genetics, and pathogenesis. Lancet Neurol. 2004, 3:291-304.
4. van de Warrenburg B.P., Sinke R.J., Kremer B. Recent advances in hereditary spinocerebellar ataxias. J. Neuropathol. Exp. Neurol. 2005, 64:171-180.
5. Holmes S.E., O'Hearn E.E., McInnis M.G., Gorelick-Feldman D.A., Kleiderlein J.J., Callahan C., Kwak N.G., Ingersoll-Ashworth R.G., Sherr M., Sumner A.J., Sharp A.H., Ananth U., Seltzer W.K., Boss M.A., Vieria-Saecker A.M., Epplen J.T., Riess O., Ross C.A., Margolis R.L. Expansion of a novel CAG trinucleotide repeat in the 5? region of PPP2R2B is associated with SCA12. Nat. Genet. 1999, 23:391-392.
6. Zoghbi H.Y., Orr H.T. Glutamine repeats and neuro-degeneration [in process citation]. Annu. Rev. Neurosci. 2000, 23:217-247.
7. Matsuura T., Yamagata T., Burgess D.L., Rasmussen A., Grewal R.P., Watase K., Khajavi M., McCall A.E., Davis C.F., Zu L., Achari M., Pulst S.M., Alonso E., Noebels J.L., Nelson D.L., Zoghbi H.Y., Ashizawa T. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat. Genet. 2000, 26:191-194.
8. Koob M.D., Moseley M.L., Schut L.J., Benzow K.A., Bird T.D., Day J.W., Ranum L.P. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat. Genet. 1999, 21:379-384.
9. O'Hearn E., Holmes S.E., Calvert P.C., Ross C.A., Margolis R.L. SCA-12: Tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion. Neurology 2001, 56:299-303.
10. Srivastava A.K., Choudhry S., Gopinath M.S., Roy S., Tripathi M., Brahmachari S.K., Jain S. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12. Ann. Neurol. 2001, 50:796-800.
11. Sinha K.K., Worth P.F., Jha D.K., Sinha S., Stinton V.J., Davis M.B., Wood N.W., Sweeney M.G., Bhatia K.P. Autosomal dominant cerebellar ataxia: SCA2 is the most frequent mutation in eastern India. J. Neurol. Neurosurg. Psychiatry 2004, 75:448-452.
12. Bahl S., Virdi K., Mittal U., Sachdeva M., Kalla A., Holmes S.E., O'Hearn E., Margolis R.L., Jain S., Srivastava A.K., Mukerji M. Evidence of a common founder for SCA12 in the Indian population. Ann. Hum. Genet. 2005, 69:1-7.
13. Fujigasaki H., Verma I.C., Camuzat A., Margolis R.L., Zander C., Lebre A.S., Jamot L., Saxena R., Anand I., Holmes S.E., Ross C.A., Durr A., Brice A. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: A study of an Indian family. Ann. Neurol. 2001, 49:117-121.
14. Worth P.F., Wood N.W. Spinocerebellar ataxia type 12 is rare in the United Kingdom. Neurology 2001, 56:419-420.
15. Brusco A., Gellera C., CAG CTG repeat expansion detection in 225 Italian families. Arch. Neurol. 2004, 61:727-733.
16. Hellenbroich Y., Schulz-Schaeffer W., Nitschke M.F., Kohnke J., Handler G., Burk K., Schwinger E., Zuhlke C. Coincidence of a large SCA12 repeat allele with a case of Creutzfeld-Jacob disease. J. Neurol. Neurosurg. Psychiatry 2004, 75:937-938.
17. Maruyama H., Izumi Y., Morino H., Oda M., Toji H., Nakamura S., Kawakami H. Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: A study of 1,286 Japanese patients. Am. J. Med. Genet. 2002, 114:578-583.
18. Matsumura R., Futamura N., Ando N., Ueno S. Frequency of spinocerebellar ataxia mutations in the Kinki district of Japan. Acta Neurol. Scand. 2003, 107:38-41.
19. Sasaki H., Yabe I., Tashiro K. The hereditary spinocerebellar ataxias in Japan. Cytogenet. Genome Res. 2003, 100:198-205.
20. Tsai H.F., Liu C.S., Leu T.M., Wen F.C., Lin S.J., Liu C.C., Yang D.K., Li C., Hsieh M. Analysis of trinucleotide repeats in different SCA loci in spinocerebellar ataxia patients and in normal population of Taiwan. Acta Neurol. Scand. 2004, 109:355-360.
21. Zhao Y., Tan E.K., Law H.Y., Yoon C.S., Wong M.C., Ng I. Prevalence and ethnic differences of autosomal-dominant cerebellar ataxia in Singapore. Clin. Genet. 2002, 62:478-481.
22. Cholfin J.A., Sobrido M.J., Perlman S., Pulst S.M., Geschwind D.H. The SCA12 mutation as a rare cause of spinocerebellar ataxia. Arch. Neurol. 2001, 58:1833-1835.
23. Sulek A., Hoffman-Zacharska D., BednarskaMakaruk M., Szirkowiec W., Zaremba J. Polymorphism of trinucleotide repeats in non-translated regions of SCA8 and SCA12 genes: Allele distribution in a Polish control group. J. Appl. Genet. 2004, 45:101-105.
24. Holmes S.E., O'Hearn E., Brahmachari S.K., Choudhry S., Srivastava A.K., Jain S., Ross C.A., Margolis R.L. Genetics of Movement Disorder 2003, 121-130. Academic Press, San Diego. S.-M. Pulst (Ed.).
25. O'Hearn E., Pletnikova O., Holmes S.E., Trojanowski J.Q., Margolis R.L. SCA12 neuropathology: Cerebral cortical and cerebellar atrophy, Purkinje cell loss, and neuronal intranuclear inclusions. Mov. Disord. 2004, 19:1124.
26. O'Hearn E. Current Therapy in Neurologic Disease 2005, Mosby, Inc., St. Louis, MO. R.T. Johnson, J.W. Griffin, J.C. McArthur (Eds.).
27. Nicoletti G., Annesi G., Carrideo S., Tomaino C., Di Costanzo A., Zappia M., Quattrone A. Familial essential tremor is not associated with SCA-12 mutation in southern Italy. Mov. Disord. 2002, 17:837-838.
28. Holmes S.E., O'Hearn E., Ross C.A., Margolis R.L. SCA12: An unusual mutation leads to an unusual spinocerebellar ataxia. Brain Res. Bull. 2001, 56:397-403.
29. Mayer R.E., Hendrix P., Cron P., Mattheis R., Stone S.R., Goris J., Merlevede W., Hofsteenge J., Hemmings B.A. Structure of the 55-kDa regulatory subunit of protein phosphatase 2A: Evidence for a neuronal-specific isoform. Biochem. J. 1991, 30:3589-3597.
30. Holmes S.E., O'Hearn E., Margolis R.L. Why is SCA12 different from other SCAs?. Cytogenet. Genome Res. 2003, 100:189-197.
31. Ince T.A., Scotto K.W. A conserved downstream element defines a new class of RNA polymerase II promoters. J. Biol. Chem. 1995, 270:30249-30252.
32. Reese M.G., Harris N.L., Eeckman F.H. Biocomputing: Proceedings of the 1996 Pacific Symposium 1996, 737-738. World Scientific Publishing Co., Singapore. L. Hunter, T. Klein (Eds.).
33. Holmes S.E., Fujigasaki H., O'Hearn E., Antonarakis S., Cooper J.K., Callahan C., Gorelick-Feldman D.A., Verma I.C., Saxena R., Durr A., Brice A., Ross C.A., Margolis R.L. Spinocerebellar ataxia type 12 (SCA12): Additional evidence for a causative role of the CAG repeat expansion in PPP2R2B. Abstr./Am. Soc. Hum. Genet. 2000, 67:200.
34. Shinagawa T., Ishiguro N., Horiuchi M., Matsui T., Okada K., Shinagawa M. Deletion of c-myb exon 9 induced by insertion of repeats. Oncogene 1997, 14:2775-2783.
35. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., Hunter K., Davies J., Shelbourne P., Buxton J., Jones C., Juvonen V., Johnson K., Harper P.S., Shaw D.J., Housman D.E. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3? end of a transcript encoding a protein kinase family member. Cell 1992, 68:799-808.
36. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., Nelville C., Narang M., Barcelo J., O'Hoy K., Leblond S., Earle-MacDonald J., DeJong P.J., Wieringa B., Korneluk R.G. Myotonic dystrophy mutation: An unstable CTG repeat in the 3? untranslated region of the gene. Science 1992, 255:1253-1255.
37. Fu Y.-H., Pizzuti A., Fenwick R.G., King J., Rajnarayan S., Dunne P.W., Dubel J., Nasser G.A., Ashizawa T., De Jong P., Wieringa B., Korneluk R., Perryman M.B., Epstein H.F., Caskey C.T. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992, 255:1256-1258.
38. Holmes S.E., O'Hearn E., Rosenblatt A., Callahan C., Hwang H.S., Ingersoll-Ashworth R.G., Fleisher A., Stevanin G., Brice A., Potter N.T., Ross C.A., Margolis R.L. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat. Genet. 2001, 29:377-378.
39. Janssens V., Goris J., Van Hoof C. PP2A: The expected tumor suppressor. Curr. Opin. Genet. Dev. 2005, 15:34-41.
40. Price N.E., Mumby M.C. Brain protein serine/threonine phosphatases. Curr. Opin. Neurobiol. 1999, 9:336-342.
41. Santoro R., Grummt I. Molecular mechanisms mediating methylation-dependent silencing of ribosomal gene transcription. Mol. Cell 2001, 8:719-725.
42. Virshup D.M. Protein phosphatase 2A:A panoply of enzymes. Curr. Opin. Cell Biol. 2000, 12:180-185.
43. Janssens V., Goris J. Protein phosphatase 2A:A highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 2001, 353:417-439.
44. Vafai S.B., Stock J.B. Protein phosphatase 2A methylation: A link between elevated plasma homocysteine and Alzheimer's disease. FEBS Lett. 2002, 518:1-4.
45. Sontag E., Hladik C., Montgomery L., Luangpirom A., Mudrak I., Ogris E., White C.L. Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J. Neuropathol. Exp. Neurol. 2004, 63:1080-1091.
46. Sontag E., Luangpirom A., Hladik C., Mudrak I., Ogris E., Speciale S., White C.L. Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J. Neuropathol. Exp. Neurol. 2004, 63:287-301.
47. Li X., Virshup D.M. Two conserved domains in regulatory B subunits mediate binding to the A subunit of protein phosphatase 2A. Eur. J. Biochem. 2002, 269:546-552.
48. Ferrigno P., Langan T.A., Cohen P. Protein phosphatase 2A1 is the major enzyme in vertebrate cell extracts that dephosphorylates several physiological substrates for cyclindependent protein kinases. Mol. Biol. Cell. 1993, 4:669-677.
49. Turowski P., Myles T., Hemmings B.A., Fernandez A., Lamb N.J. Vimentin dephosphorylation by protein phosphatase 2A is modulated by the targeting subunit B55. Mol. Biol. Cell 1999, 10:1997-2015.
50. Sontag E., Nunbhakdi-Craig V., Lee G., Bloom G.S., Mumby M.C. Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A. Neuron 1996, 17:1201-1207.
51. Strack S., Zaucha J.A., Ebner F.F., Colbran R.J., Wadzinski B.E. Brain protein phosphatase 2A: Developmental regulation and distinct cellular and subcellular localization by B subunits. J. Comp. Neurol. 1998, 392:515-527.
52. Strack S., Chang D., Zaucha J.A., Colbran R.J., Wadzinski B.E. Cloning and characterization of B delta, a novel regulatory subunit of protein phosphatase 2A. FEBS Lett. 1999, 460:462-466.
53. Schmidt K., Kins S., Schild A., Nitsch R.M., Hemmings B.A., Gotz J. Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A. Eur. J. Neurosci. 2002, 16:2039-2048.
54. Dagda R.K., Zaucha J.A., Wadzinski B.E., Strack S. A developmentally regulated, neuron-specific splice variant of the variable subunit Bbeta targets protein phosphatase 2A to mitochondria and modulates apoptosis. J. Biol. Chem. 2003, 278:24976-24985.
55. Groves M.R., Hanlon N., Turowski P., Hemmings B.A., Barford D. The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs. Cell 1999, 96:99-110.
56. Egloff M.P., Cohen P.T., Reinemer P., Barford D. Crystal structure of the catalytic subunit of human protein phosphatase 1 and its complex with tungstate. J. Mol. Biol. 1995, 254:942-959.
57. Goldberg J., Huang H.B., Kwon Y.G., Greengard P., Nairn A.C., Kuriyan J. Three-dimensional structure of the catalytic subunit of protein serine/threonine phophatase-1. Nature 1995, 376:745-753.
58. Terrak M., Kerff F., Langsetmo K., Tao T., Dominguez R. Structural basis of protein phosphatase 1 regulation. Nature 2004, 429:780-784.
59. Strack S., Ruediger R., Walter G., Dagda R.K., Barwacz C.A., Cribbs J.T. Protein phosphatase 2A holoenzyme assembly: Identification of contacts between B-family regulatory and scaffolding A subunits. J. Biol. Chem. 2002, 277:20750-20755.
60. Dagda R.K., Barwacz C.A., Cribbs J.T., Strack S. Unfolding-resistant translocase targeting: A novel mechanism for outer mitochondrial membrane localization exemplified by the Bbeta 2 regulatory subunit of protein phosphatase 2A. J. Biol. Chem. 2005, 280:27375-27382.
61. Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W., Naylor S.L., Day J.W., Ranum L.P. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-867.
62. Fardaei M., Rogers M.T., Thorpe H.M., Larkin K., Hamshere M.G., Harper P.S., Brook J.D. Three proteins MBNL, MBLL and MBXL, colocalize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet. 2002, 11:805-814.
63. Satoh J., Yamamura T. Gene expression profile following stable expression of the cellular prion protein. Cell Mol. Neurobiol. 2004, 24:793-814.